04/17/2024
3:18 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
7:01 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:44 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:10 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:28 PM | Haemonetics (Subject)
Neuberger Berman Group LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
4:49 PM | Capital Research Global Investors (Filed by)
Haemonetics (Subject)
| Form SC 13G/A | |
02/08/2024
9:21 AM | Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
|
02/08/2024
5:05 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/08/2024
5:06 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/12/2023
5:09 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:36 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
5:19 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
5:16 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
3:23 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
3:27 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:10 AM | Haemonetics (Filer)
| Form 8-K/A | |
10/10/2023
5:06 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:16 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:19 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:20 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
11:19 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
12:22 PM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:23 PM | Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
1:23 PM | Dockendorff Charles J (Reporting)
Haemonetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
5:09 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
5:01 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
3:17 PM | Haemonetics (Issuer)
Llorens Josep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
11:55 AM | Haemonetics (Subject)
Llorens Josep (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
3:17 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:14 AM | Haemonetics (Filer)
| Form ARS | |
06/16/2023
5:08 AM | Haemonetics (Filer)
| Form DEF 14A | |
06/16/2023
5:10 AM | Haemonetics (Filer)
| Form DEFA14A | |
06/07/2023
1:03 PM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:19 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
9:23 AM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
3:37 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:34 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:35 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:36 PM | Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
3:16 PM | Haemonetics (Issuer)
Llorens Josep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
3:17 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
05/11/2023
5:05 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
